TASIGNA caps 150 mg 112 pce

7680580070049 CH-58007 L01EA03 07.16.1.

Active substances:

Nilotinibum
TASIGNA caps 150 mg 112 pce
TASIGNA caps 150 mg 112 pce
TASIGNA caps 150 mg 112 pce
1 / 3
google

Details

Product number
5800702
CPT
-
Packaging group
112
Unit
Kapsel(n)
Composition
nilotinibum 150 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 117.08 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.

Articles (1)

Tasigna 150 mg, Kapseln
Kapseln
112
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2022
Patient information leaflet
Français
09/08/2022
Patient information leaflet
Italien
09/08/2022
Professional SmPC
Allemand
09/08/2022
Professional SmPC
Français
09/08/2022
Professional SmPC
Italien
09/08/2022

Detailed composition

Substance Quantity Type Category
nilotinibum
150.0 MG Substance Wirkstoff (Principe actif)
nilotinibi hydrochloridum monohydricum
- Substance WIZUS
lactosum monohydricum
117.08 MG Substance HNIDK
crospovidonum
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio 28 per centum
- Substance HNIDK

Reimbursement information

Public price
CHF 1999.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2010

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
58007
Drug name
Tasigna, Kapseln
Galenic form
KAHA
ATC Code
L01EA03
Authorization status
Z
Dispensation category
A
First authorization
24/07/2007
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung der chronischen myeloischen Leukämie

Packaging details

Description (FR)
TASIGNA caps 150 mg 112 pce
Description (DE)
TASIGNA Kaps 150 mg 112 Stk
Market launch
24/08/2010
Narcotic (BTM)
No

Available generics

Nilotinib Accord, Hartkapseln
GTIN: 7680701780024
CHF 1036.95
View
Nilotinib Accord, Hartkapseln
GTIN: 7680701780031
CHF 484.75
View
Nilotinib Accord, Hartkapseln
GTIN: 7680701780048
CHF 1552.60
View
Nilotinib Zentiva, Hartkapseln
GTIN: 7680698460022
CHF 1018.20
View
Nilotinib Zentiva, Hartkapseln
GTIN: 7680698460039
CHF 483.60
View
Nilotinib Zentiva, Hartkapseln
GTIN: 7680698460046
CHF 1552.20
View

Other packaging sizes

TASIGNA caps 200 mg 28 pce
28 KAP
GTIN: 7680580070018
View
TASIGNA caps 200 mg 112 pce
112 KAP
GTIN: 7680580070025
View
TASIGNA caps 50 mg 120 pce
120 KAP
GTIN: 7680580070056
View
Buy us a coffee Explore the data